Deals, Partnering

Daxor announces that the Mayo Clinic acquires BVA-100 blood volume analyzer

Posted on 12 January 2012

Tags: ,

Daxor announced the receipt of a signed trial agreement from the Mayo Clinic in Scottsdale, Arizona.

This agreement will provide the Mayo Clinic with a Blood Volume Analyzer-100 (BVA-100), an instrument which enables semi-automated measurement of a patient's total blood volume, red blood cell volume and plasma volume. 

The Mayo Clinic in Arizona is a five-story, 240-exam room outpatient clinic offering outpatient surgery, laboratory, diagnostic testing, imaging and pharmacy services. The clinic has 244 licensed hospital beds with 18 operating rooms, an urgent care/emergency room, a transplant center and a full-service clinical laboratory. It also offers diagnostic imaging and non-invasive heart tests and lung testing services, and operates a Level II emergency department serving patients from the surrounding area, as well as from all 50 states and several foreign countries.

Dr. Joseph Feldshuh, the President of Daxor, stated that the mission of Daxor is to make the Blood Volume Analyzer a standard of care in the treatment of critical conditions such as heart failure and intensive care unit medicine. At the present time hundreds of thousands of critically ill patients are being treated on the basis of clinical guesses, which have been demonstrated on the basis of published studies, to be inaccurate. The decision, for example, to give or withhold a transfusion to a patient should be based on precise measurements which are available by actually measuring a patient's blood volume.

Daxor Corporation manufactures and markets the BVA-100, which is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website at


See more deal information at Current Agreements (subscription required)

Print Friendly, PDF & Email

Leave a Reply